Please Wait...

Dr. Colin Miller Joins Alacrita Consulting, Appointed as Co-Chair of BioClinica's Musculoskeletal Scientific Advisory Board

May 7, 2015

BioClinica®, the world’s leading Medical Imaging service provider for clinical trials, and Alacrita, the transatlantic life science management consulting firm, announced today that Dr. Colin Miller has been appointed as Associate Partner at Alacrita. In his new role, Dr. Miller will be responsible for providing expert advice to the firm’s pharmaceutical and biotechnology clients, as well as overseeing a new partnership with BioClinica. Dr. Miller will continue to provide scientific support for major clinical trial imaging programs at BioClinica and will serve as Co-Chair of BioClinica’s Musculoskeletal Scientific Advisory Board.

Dr. Miller has made significant contributions to BioClinica’s growth for over two decades, as a leader of Medical Affairs and more recently as Vice President of Strategic Development. His scientific expertise and leadership has steered numerous clinical programs, forged successful collaborations with industry and academic partners, and identified key areas of expansion for BioClinica.

“This opportunity enables me to apply scientific acumen and technical insight I have garnered over the years at BioClinica to a broader range of companies seeking to thrive in the life sciences sector.” said Dr. Miller. “During this next phase of my career, I am pleased to continue a close relationship with my BioClinica colleagues and clients, while growing with Alacrita in new areas of clinical research.”

Dr. Miller brings with him a tremendous amount of industry experience, ambition, and enthusiasm for medical imaging. “His focused expertise in medical imaging and clinical trial design makes him an ideal addition to our high caliber consulting group” said Robert Johnson, Founding Partner at Alacrita. “As a world-class life science consulting firm, we fully support his commitment to BioClinica and the important clinical trials which they support.”  

In his new post, Dr. Miller will continue to work closely with BioClinica’s Medical Imaging team and remains a critical driving force for BioClinica’s Musculoskeletal Scientific Advisory Board, designed to provide therapeutic area expertise for clinical trial sponsors developing new treatments.

“We are excited for Colin’s new role and the opportunity to foster a strategic partnership with Alacrita” said David Herron, Executive Vice President and President of BioClinica’s Medical Imaging, Cardiovascular Safety, and Molecular Markers business segment. “We look forward to our continued collaboration with Colin, leveraging his extensive scientific expertise and industry experience in support of our clients.”

For more information on BioClinica’s specialized clinical trial services, visit
For more information on Alacrita’s expertise-based consulting, visit

About Alacrita
Alacrita is a rapidly growing, transatlantic management consulting firm providing expertise-based services to the pharmaceutical, biotechnology and life science sectors. The firm is supported by an unrivalled team of experts who operate across the spectrum of life sciences. They combine extensive international industry experience (strategic, technical and commercial), broad functional capabilities and a track record of success across the industry.

About Bioclinica

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica's experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company's offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance and trial management. The company's thousands of employees serve more than 500 pharmaceutical, biotechnology and device organizations – including all top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.

Learn more about Bioclinica at and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

IRT Support Specialist Seeking a project support specialist in Groton, CT - Great opportunity for those applying te…
Bioclinica (Yesterday)
Attend Bioclinica's session at #OCTNE "When EDC is not enough" – and then visit us at booth #38! #bioclinica…
Bioclinica (3 days ago)
Looking for an #rtsm solution that reduces time, implementation effort and cost for complex global trials? Learn mo…
Bioclinica (3 days ago)
Are site payment a challenge? Meet our expert Meghan Harrington to learn more about our Site & Patient Payments tec…
Bioclinica (1 week ago)
With 25+ years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in pro…
Bioclinica (2 weeks ago)
Single platform. Any device. Best-in-class enterprise electronic data capture – and it makes eSource simple. Learn…
Bioclinica (2 weeks ago)